Yes, Palforzia is FDA approved. The U.S. Food and Drug Administration (FDA) approved Palforzia on January 31, 2020. This approval marked a significant advancement in the management of peanut allergies, offering a new therapeutic option for those affected.
Palforzia, a peanut allergen extract, is used to help reduce the severity of allergic reactions, including anaphylaxis, when someone accidentally consumes peanuts. However, it is not a treatment for allergic reactions that have already started.
Key Points:
Palforzia should be taken exactly as prescribed by a doctor. The initial dose and any dose increases must be administered in a healthcare setting under medical supervision to monitor for any adverse reactions. The medication is taken orally, mixed with a small amount of food like applesauce, yogurt, or pudding, and should not be mixed with liquids.
Initial Dose Escalation (Ages 4 to 17):
Maintenance Dose:
Common side effects of Palforzia include:
Severe side effects requiring immediate medical attention include:
Palforzia can cause severe or life-threatening allergic reactions. Patients must have injectable epinephrine on hand at all times while using Palforzia and should seek emergency medical help if they experience any signs of a severe allergic reaction.
Contraindications:
Palforzia represents an important development in the treatment of peanut allergies, offering a way to mitigate the severity of allergic reactions in case of accidental exposure. Approved by the FDA on January 31, 2020, it provides a structured, monitored approach to desensitization for individuals with peanut allergies, improving their safety and quality of life.
In the Synapse database, you can stay updated on the latest research and development advances of all drugs. This service is accessible anytime and anywhere, with updates available daily or weekly. Use the "Set Alert" function to stay informed. Click on the image below to embark on a brand new journey of drug discovery!